This page is part of the FHIR Specification (v4.3.0-snapshot1: Release 4B Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Basic Example of a drug authorization for Equilidem
{ "resourceType": "RegulatedAuthorization", "id": "basic-drug-auth", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div><p>Resource "basic-drug-auth" </p></div><p><b>subject</b>: <a>MedicinalProductDefinition/equilidem</a></p><p><b>type</b>: Regulatory Drug Marketing Approval <span> ()</span></p><p><b>status</b>: active <span> ([not stated]#active)</span></p><p><b>statusDate</b>: 2016-01-01</p><p><b>holder</b>: <a>Organization/EqlidrugCo: EquiliDrugCo Holdings Inc.</a></p><p><b>regulator</b>: <a>Organization/FDA: FDA</a></p></div>" }, "subject": [ { "reference": "MedicinalProductDefinition/equilidem" } ], "type": { "text": "Regulatory Drug Marketing Approval" }, "status": { "coding": [ { "code": "active" } ] }, "statusDate": "2016-01-01", "holder": { "reference": "Organization/EqlidrugCo", "display": "EquiliDrugCo Holdings Inc." }, "regulator": { "reference": "Organization/FDA", "display": "FDA" } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.